- London's FTSE 100 fell on Friday with sentiment negatively affected by weak German data and worsening US-China trade deal prospects, after US Vice President Mike Pence criticised the Chinese as an aggressive and destabilising force. UK stocks were also impacted as markets waited for a breakthrough on a Brexit extension or a potential election.

At 11.30, the benchmark FTSE 100 index was down 39.4 points, or 0.54%, at 7,288.85.


Banking group Barclays gained 1.5p to 167.9p as it reported a fall in third quarter profit that nevertheless beat market expectations.

The lender also said that meeting its performance targets for this year and the next had become more challenging, owing to lower interest rates and macroeconomic uncertainty.

Miner and commodities trader Glencore shed 0.8% to 230.5p after it reported a 4% fall in year-to-date copper production, as it shuttered a smelter in Zambia and re-optimised a mine in the Democratic Republic of the Congo.

Advertising company WPP rallied 6% to 973.8p on revealing a 5.2% rise in third-quarter revenue, buoyed by new contracts wins with Mondelez and eBay.

Pan-African fuels and lubricants distributor Vivo Energy advanced 2.4p to 122.4p after delivering another record quarter, with third quarter sales volume up 15%, as well as a confident outlook statement.

FTSE 250 newcomer Airtel Africa improved 1.1% to 56.6p as the Kenya-based telecoms company reported a 'strong' set of half year results.

Business-to-business media and events company Ascential cheapened 5.5% to 343.8p as it informed the market that its Money 20/20 China event will not be going ahead due to a 'short-term hiatus' of international companies entering the Chinese financial technology (fintech) market.

Chemicals company Synthomer sank 10.7% to 276.4p after it announced that it had experienced a slower overall trading environment in the third quarter, which it said was expected to continue into the fourth quarter and into 2020.

Plastic and fibre product supplier Essentra shed 2.7% to 411.8p as its like-for-like revenue declined in the third quarter of the year, owing to some short-term Brexit impacts and a tougher macroeconomic environment.


Biomarker developer Oxford BioDynamics was flat at 94.5p despite welcome news that Mitsubishi Tanabe Pharma America had enrolled the first patient in a new clinical study that involved use of the company's technology.

Virtual reality technology company VR Education sparked up 25% to 7.5p on the back of news that its Engage platform had been selected by Facebook for its Oculus independent software vendors programme.

Story provided by